Literature DB >> 24180461

Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.

Laura Izquierdo1, Mercedes Ingelmo-Torres, Carmen Mallofré, Juan José Lozano, Marie Verhasselt-Crinquette, Xavier Leroy, Pierre Colin, Eva Comperat, Morgan Roupret, Antonio Alcaraz, Lourdes Mengual.   

Abstract

OBJECTIVE: To examine the microRNA (miRNA) expression pattern in tumour samples from patients with progressing and non-progressing upper tract urothelial carcinoma (UTUC) in order to identify putative miRNAs that may be used as prognostic markers. PATIENTS AND METHODS: We conducted a multicentre, retrospective study of formalin-fixed paraffin-embedded tissue samples from 150 patients with UTUC who had undergone radical nephroureterectomy. Global miRNA expression patterns were analysed in 18 selected samples from patients with UTUC using TaqMan arrays. The differential expression of five key miRNAs was validated by quantitative polymerase chain reaction in an independent cohort of 132 samples from patients with UTUC. Models to predict tumour progression and cancer-specific survival that included miRNA expression patterns were developed by Cox regression analysis.
RESULTS: Twenty-six miRNAs were found to be aberrantly expressed between samples from patients with progressing and non-progressing UTUC and five of these were selected for subsequent studies. The regression analysis identified tumour stage and miR-31 and miR-149 expression as independently associated with tumour progression and tumour stage and miR-149 expression as independently associated with cancer-specific survival. The risk scores derived from these miRNA models were able to discriminate two groups with a highly significantly different probability of tumour progression (hazard ratio [HR] 4.78; P < 0.001) and death (HR 276; P = 0.004).
CONCLUSIONS: There is a differential miRNA expression pattern between patients with progressing and non-progressing UTUC. The identification of new miRNAs associated with a high probability of tumour recurrence and cancer-specific survival in patients with UTUC and their combination in a robust, easy-to-use and reliable algorithm may help tailor treatment and surveillance strategies in these patients.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  microRNA; prognosis; quantitative PCR; upper tract urothelial carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24180461     DOI: 10.1111/bju.12551

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

Review 2.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

3.  Prognostic role of microRNA-31 in various cancers: a meta-analysis.

Authors:  Shuwei Wang; Jun Hu; Dongsheng Zhang; Juan Li; Qiang Fei; Yueming Sun
Journal:  Tumour Biol       Date:  2014-08-20

Review 4.  Regulation and functions of MicroRNA-149 in human cancers.

Authors:  Yingru Zhi; Hao Zhou; Abudoureyimu Mubalake; Ying Chen; Bei Zhang; Kai Zhang; Xiaoyuan Chu; Rui Wang
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

5.  Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.

Authors:  Stephanie Kriebel; Doris Schmidt; Stefan Holdenrieder; Diane Goltz; Glen Kristiansen; Rudolf Moritz; Christian Fisang; Stefan C Müller; Jörg Ellinger
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

Review 6.  MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.

Authors:  Tarek Shalaby; Giulio Fiaschetti; Martin Baumgartner; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2014-11-24       Impact factor: 5.923

7.  Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo.

Authors:  Le Tao; Yigang Zeng; Jun Wang; Zhihong Liu; Bing Shen; Jifu Ge; Yong Liu; Yifeng Guo; Jianxin Qiu
Journal:  Mol Med Rep       Date:  2015-09-15       Impact factor: 2.952

Review 8.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

9.  New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.

Authors:  Apostolos Zaravinos; George I Lambrou; Nikos Mourmouras; Patroklos Katafygiotis; Gregory Papagregoriou; Krinio Giannikou; Dimitris Delakas; Constantinos Deltas
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection.

Authors:  Jun Tao; Xiao Yang; Pengchao Li; Jifu Wei; Xiaheng Deng; Yidong Cheng; Chao Qin; Xiaobing Ju; Xiaoxin Meng; Jie Li; Min Gu; Qiang Lu; Changjun Yin
Journal:  Mol Med Rep       Date:  2015-08-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.